Essential Role of GATA2 in the Negative Regulation of Type 2 Deiodinase Gene by Liganded Thyroid Hormone Receptor β2 in Thyrotroph

The inhibition of thyrotropin (thyroid stimulating hormone; TSH) by thyroid hormone (T3) and its receptor (TR) is the central mechanism of the hypothalamus-pituitary-thyroid axis. Two transcription factors, GATA2 and Pit-1, determine thyrotroph differentiation and maintain the expression of the β subunit of TSH (TSHβ). We previously reported that T3-dependent repression of the TSHβ gene is mediated by GATA2 but not by the reported negative T3-responsive element (nTRE). In thyrotrophs, T3 also represses mRNA of the type-2 deiodinase (D2) gene, where no nTRE has been identified. Here, the human D2 promoter fused to the CAT or modified Renilla luciferase gene was co-transfected with Pit-1 and/or GATA2 expression plasmids into cell lines including CV1 and thyrotroph-derived TαT1. GATA2 but not Pit-1 activated the D2 promoter. Two GATA responsive elements (GATA-REs) were identified close to cAMP responsive element. The protein kinase A activator, forskolin, synergistically enhanced GATA2-dependent activity. Gel-shift and chromatin immunoprecipitation assays with TαT1 cells indicated that GATA2 binds to these GATA-REs. T3 repressed the GATA2-induced activity of the D2 promoter in the presence of the pituitary-specific TR, TRβ2. The inhibition by T3-bound TRβ2 was dominant over the synergism between GATA2 and forskolin. The D2 promoter is also stimulated by GATA4, the major GATA in cardiomyocytes, and this activity was repressed by T3 in the presence of TRα1. These data indicate that the GATA-induced activity of the D2 promoter is suppressed by T3-bound TRs via a tethering mechanism, as in the case of the TSHβ gene.

[1]  J. Harney,et al.  The selective loss of the type 2 iodothyronine deiodinase in mouse thyrotrophs increases basal TSH but blunts the thyrotropin response to hypothyroidism. , 2015, Endocrinology.

[2]  Mo-Fang Liu,et al.  Thyroid hormone regulates muscle fiber type conversion via miR-133a1 , 2014, The Journal of cell biology.

[3]  Hirotoshi Nakamura,et al.  Essential Role of TEA Domain Transcription Factors in the Negative Regulation of the MYH 7 Gene by Thyroid Hormone and Its Receptors , 2014, PloS one.

[4]  Ksenia Tonyushkina,et al.  Embryonic exposure to excess thyroid hormone causes thyrotrope cell death. , 2014, The Journal of clinical investigation.

[5]  Csaba Fekete,et al.  Coordination of hypothalamic and pituitary T3 production regulates TSH expression. , 2013, The Journal of clinical investigation.

[6]  D. Yee,et al.  BMP-binding protein twisted gastrulation is required in mammary gland epithelium for normal ductal elongation and myoepithelial compartmentalization. , 2013, Developmental biology.

[7]  F. Wondisford,et al.  Fundamentally distinct roles of thyroid hormone receptor isoforms in a thyrotroph cell line are due to differential DNA binding. , 2012, Molecular endocrinology.

[8]  M. Odero,et al.  The role of the GATA2 transcription factor in normal and malignant hematopoiesis. , 2012, Critical reviews in oncology/hematology.

[9]  Hirotoshi Nakamura,et al.  Liganded Thyroid Hormone Receptor Inhibits Phorbol 12-O-Tetradecanoate-13-Acetate-Induced Enhancer Activity via Firefly Luciferase cDNA , 2012, PloS one.

[10]  Hirotoshi Nakamura,et al.  Negative Regulation of the Thyrotropin β Gene by Thyroid Hormone , 2011 .

[11]  Hirotoshi Nakamura,et al.  GATA2 Mediates Thyrotropin-Releasing Hormone-Induced Transcriptional Activation of the Thyrotropin β Gene , 2011, PloS one.

[12]  J. Schwabe,et al.  Negative regulation by nuclear receptors: a plethora of mechanisms , 2011, Trends in Endocrinology & Metabolism.

[13]  R. DePinho,et al.  The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. , 2010, The Journal of clinical investigation.

[14]  R. Hoermann,et al.  Complex relationship between free thyroxine and TSH in the regulation of thyroid function. , 2010, European journal of endocrinology.

[15]  P. Davis,et al.  Molecular aspects of thyroid hormone actions. , 2010, Endocrine reviews.

[16]  S. Friedrichsen,et al.  Analysis of hypertrophic thyrotrophs in pituitaries of athyroid Pax8-/- mice. , 2009, Endocrinology.

[17]  Hirotoshi Nakamura,et al.  Functions of PIT1 in GATA2-dependent transactivation of the thyrotropin beta promoter. , 2008, Journal of molecular endocrinology.

[18]  A. Aranda,et al.  Thyroid hormone-mediated activation of the ERK/dual specificity phosphatase 1 pathway augments the apoptosis of GH4C1 cells by down-regulating nuclear factor-kappaB activity. , 2008, Molecular endocrinology.

[19]  J. Weitzel.  To bind or not to bind – how to down-regulate target genes by liganded thyroid hormone receptor? , 2008, Thyroid research.

[20]  J. Harney,et al.  Activation of thyroid hormone is transcriptionally regulated by epidermal growth factor in human placenta-derived JEG3 cells. , 2008, Endocrinology.

[21]  A. Bianco,et al.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. , 2008, Endocrine reviews.

[22]  M. Nemer.  Genetic insights into normal and abnormal heart development. , 2008, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[23]  A. Bianco,et al.  Activation and inactivation of thyroid hormone by deiodinases: Local action with general consequences , 2008, Cellular and Molecular Life Sciences.

[24]  Mahesh P. Gupta,et al.  Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. , 2007, Journal of molecular and cellular cardiology.

[25]  Hirotoshi Nakamura,et al.  Essential role of GATA2 in the negative regulation of thyrotropin beta gene by thyroid hormone and its receptors. , 2007, Molecular endocrinology.

[26]  A. Bianco,et al.  Characterization of the Nuclear Factor-κB Responsiveness of the Human dio2 Gene , 2006 .

[27]  Kwang-Soo Kim,et al.  GATA‐3 regulates the transcriptional activity of tyrosine hydroxylase by interacting with CREB , 2006, Journal of neurochemistry.

[28]  J. Tijssen,et al.  Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression. , 2006, European journal of endocrinology.

[29]  J. Harney,et al.  Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary thyrotropin feedback mechanism. , 2006, Endocrinology.

[30]  S. Fiering,et al.  Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice. , 2006, Endocrinology.

[31]  A. Bianco,et al.  Characterization of the nuclear factor-kappa B responsiveness of the human dio2 gene. , 2006, Endocrinology.

[32]  S. Orkin,et al.  Phosphatidylinositol 3-Kinase/Akt Induced by Erythropoietin Renders the Erythroid Differentiation Factor GATA-1 Competent for TIMP-1 Gene Transactivation , 2005, Molecular and Cellular Biology.

[33]  B. Gereben,et al.  Pretranslational regulation of type 2 deiodinase. , 2005, Thyroid : official journal of the American Thyroid Association.

[34]  Masayuki Yamamoto,et al.  Rapid turnover of GATA‐2 via ubiquitin‐proteasome protein degradation pathway , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[35]  M. Federici,et al.  Phosphorylation of GATA2 by Akt Increases Adipose Tissue Differentiation and Reduces Adipose Tissue–Related Inflammation: A Novel Pathway Linking Obesity to Atherosclerosis , 2005, Circulation.

[36]  E. Guzmán,et al.  Functional characterisation of the CRE/TATA box unit of type 2 deiodinase gene promoter in a human choriocarcinoma cell line. , 2004, Journal of Molecular Endocrinology.

[37]  Hirotoshi Nakamura,et al.  Thyroid-hormone-dependent negative regulation of thyrotropin beta gene by thyroid hormone receptors: study with a new experimental system using CV1 cells. , 2004, The Biochemical journal.

[38]  M. S. Wagner,et al.  Hypothyroidism induces type 2 iodothyronine deiodinase expression in mouse heart and testis. , 2003, Journal of molecular endocrinology.

[39]  M. Mori,et al.  Expression of Type 2 Iodothyronine Deiodinase in Corticotropin-secreting Mouse Pituitary Tumor Cells Is Stimulated by Glucocorticoid and Corticotropin- Releasing Hormone , 2022 .

[40]  M. Lazar.  Thyroid hormone action: a binding contract. , 2003, The Journal of clinical investigation.

[41]  C. Morisco,et al.  The different cardiac expression of the type 2 iodothyronine deiodinase gene between human and rat is related to the differential response of the Dio2 genes to Nkx-2.5 and GATA-4 transcription factors. , 2003, Molecular endocrinology.

[42]  A. Aranda,et al.  The thyroid hormone receptor antagonizes CREB‐mediated transcription , 2003, The EMBO journal.

[43]  M. Buchfelder,et al.  Expression of 5'-deiodinase enzymes in normal pituitaries and in various human pituitary adenomas. , 2002, European journal of endocrinology.

[44]  P. Larsen,et al.  Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. , 2002, Endocrine reviews.

[45]  S. Fiering,et al.  Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. , 2001, Molecular endocrinology.

[46]  D. D. Brown,et al.  Timing of metamorphosis and the onset of the negative feedback loop between the thyroid gland and the pituitary is controlled by type II iodothyronine deiodinase in Xenopus laevis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  T. Oka,et al.  Isolation and characterization of the 5′-upstream and untranslated regions of the mouse type II iodothyronine deiodinase gene , 2000, Molecular and Cellular Endocrinology.

[48]  G. Canettieri,et al.  Isolation of human type 2 deiodinase gene promoter and characterization of a functional cyclic adenosine monophosphate response element. , 2000, Endocrinology.

[49]  Y Hosoi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Expression and Regulation of Type II Iodothyronine Deiodinase in Cultured Human Skeletal Muscle Cells* , 2022 .

[50]  B. Lowell,et al.  Divergent roles for thyroid hormone receptor beta isoforms in the endocrine axis and auditory system. , 1999, The Journal of clinical investigation.

[51]  M. Rosenfeld,et al.  Reciprocal Interactions of Pit1 and GATA2 Mediate Signaling Gradient–Induced Determination of Pituitary Cell Types , 1999, Cell.

[52]  F. Haddad,et al.  In vivo regulation of beta-MHC gene in rodent heart: role of T3 and evidence for an upstream enhancer. , 1999, American Journal of Physiology.

[53]  F. Haddad,et al.  In vivo regulation of β-MHC gene in rodent heart: role of T3 and evidence for an upstream enhancer. , 1999, American journal of physiology. Cell physiology.

[54]  B. Yusta,et al.  The Thyrotropin β-Subunit Gene Is Repressed by Thyroid Hormone in a Novel Thyrotrope Cell Line, Mouse TαT1 Cells1 , 1998 .

[55]  B. Yusta,et al.  The thyrotropin beta-subunit gene is repressed by thyroid hormone in a novel thyrotrope cell line, mouse T alphaT1 cells. , 1998, Endocrinology.

[56]  B. Haugen,et al.  Pit-1 and GATA-2 Interact and Functionally Cooperate to Activate the Thyrotropin β-Subunit Promoter* , 1997, The Journal of Biological Chemistry.

[57]  É. Fekete,et al.  Rapid stimulation of type I 5′-deiodinase in rat pituitaries by 3,3′,5-triiodo-l-thyronine , 1995, Molecular and Cellular Endocrinology.

[58]  D. Steger,et al.  GATA-binding proteins regulate the human gonadotropin alpha-subunit gene in the placenta and pituitary gland , 1994, Molecular and cellular biology.

[59]  J. D. Engel,et al.  DNA-binding specificities of the GATA transcription factor family , 1993, Molecular and cellular biology.

[60]  S. Orkin,et al.  Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. , 1992, The Journal of biological chemistry.

[61]  H. Imura,et al.  Demonstration of nuclear 3,5,3'-triiodothyronine receptor proteins in gonadotrophs and corticotrophs in rat anterior pituitary by double immunohistochemical staining. , 1991, Endocrinology.

[62]  K. Yoshinaga,et al.  Thyroxine 5'-deiodinase in human anterior pituitary tumors. , 1990, The Journal of clinical endocrinology and metabolism.

[63]  F. Wondisford,et al.  Thyroid hormone inhibition of human thyrotropin beta-subunit gene expression is mediated by a cis-acting element located in the first exon. , 1989, Journal of Biological Chemistry.

[64]  M. Greer,et al.  Anterior pituitary type II thyroxine 5'-deiodinase activity is not affected by lesions of the hypothalamic paraventricular nucleus which profoundly depress pituitary thyrotropin secretion. , 1988, Endocrinology.

[65]  A. Watson,et al.  Regulation of thyroxine 5'-deiodinase activity by 3,5,3'-triiodothyronine in cultured rat anterior pituitary cells. , 1984, Endocrinology.

[66]  W. Bridson,et al.  Isolation of hormone-producing clonal lines of human choriocarcinoma. , 1971, The Journal of clinical endocrinology and metabolism.

[67]  A. Tashjian,et al.  Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. , 1968, Endocrinology.